{"@id":"https://bioecon.ru/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","json":"https://cn.bioecon.ru/api/v1/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/index.json"},"id":"oral-t-cell-immunotherapy-via-attenuated-bacteria","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/wildtype/","https://bioecon.ru/companies/enzymicals-ag/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/integriculture/"]},"maturity":7,"name":"口服减毒细菌载体递送质粒激活全身T细胞免疫","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"染色体不可逆代谢关键基因敲除减毒"},{"n":2,"title":"真核高效表达质粒工程化转化装载"},{"n":3,"title":"肠溶高分子胶囊口服靶向派氏结摄取"},{"n":4,"title":"质粒胞内裂解释放与全身特异性杀伤"}],"summary":"利用基因敲除严格减毒的活体细菌载体（如沙门氏菌aroA/aroD突变株）携带真核表达质粒，封装于耐胃酸肠溶胶囊中口服给药，特异性靶向肠道派氏结树突状细胞，激发全身性针对结直肠癌及胰腺癌的特异性杀伤T细胞免疫。","url":"/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","verified":"2026-11-22"}